FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gregory Dore

Research Profile

Disorders

Geographic Areas

Activities & Behaviors

Intravenous Substance Abuse

Living Beings

Chemicals & Drugs

Concepts & Ideas

Procedures

Highly Active Antiretroviral Therapy

Co-author Network

Publications

TOP 3
Gail V Matthews; Peter A Revill; Kiat Ruxrungtham; Joseph Sasadeusz; Melissa Saulynas; Eric C Seaberg; Anchalee Avihingsanon; Scott Bowden; Gregory J Dore; Robert Finlayson; Jennifer F Hoy; Sharon R Lewin; Margaret Littlejohn; Stephen Locarnini; Chloe L Thio
Patterns and causes of suboptimal response to tenofovir-based therapy in individuals coinfected with HIV and hepatitis B virus.
Jason Grebely; Megan Oser; Lynn E Taylor; Gregory J Dore
Breaking down the barriers to hepatitis C virus (HCV) treatment among individuals with HCV/HIV coinfection: action required at the system, provider, and patient levels.
Matthew T Kitson; Geoffrey W McCaughan; William Sievert; Martin Weltman; Peter Button; Wendy S Cheng; Darrell H G Crawford; Gregory J Dore; Jacob George; Stuart K Roberts
Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gregory Dore (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Gail V Matthews; Peter A Revill; Kiat Ruxrungtham; Joseph Sasadeusz; Melissa Saulynas; Eric C Seaberg; Anchalee Avihingsanon; Scott Bowden; Gregory J Dore; Robert Finlayson; Jennifer F Hoy; Sharon R Lewin; Margaret Littlejohn; Stephen Locarnini; Chloe L Thio
Patterns and causes of suboptimal response to tenofovir-based therapy in individuals coinfected with HIV and hepatitis B virus.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2013;56(9):e87-94.
2013: Jason Grebely; Megan Oser; Lynn E Taylor; Gregory J Dore
Breaking down the barriers to hepatitis C virus (HCV) treatment among individuals with HCV/HIV coinfection: action required at the system, provider, and patient levels.
The Journal of infectious diseases 2013;207 Suppl 1():S19-25.
2013: Matthew T Kitson; Geoffrey W McCaughan; William Sievert; Martin Weltman; Peter Button; Wendy S Cheng; Darrell H G Crawford; Gregory J Dore; Jacob George; Stuart K Roberts
Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection.
Journal of hepatology 2013;58(3):467-72.
2013: Gail V Matthews; Kiat Ruxrungtham; Joseph Sasadeusz; Rachel J Ali; Janaki Amin; Anchalee Avihingsanon; Scott Bowden; Rachel Hammond; Sharon R Lewin; Margaret Littlejohn; Stephen L Locarnini; Gregory J Dore
Quantitative HBsAg and HBeAg Predict Hepatitis B Seroconversion after Initiation of HAART in HIV-HBV Coinfected Individuals.
PloS one 2013;8(4):e61297.
2012: Behzad Hajarizadeh; Jason Grebely; Gregory J Dore
Case definitions for acute hepatitis C virus infection: a systematic review.
Journal of hepatology 2012;57(6):1349-60.
2012: Hla-Hla Thein; Scott R Walter; Janaki Amin; Jacob George; Heather F Gidding; Matthew G Law; Gregory J Dore
Survival after diagnosis of hepatocellular carcinoma and potential impact of treatment in a hepatitis B or C infected cohort.
Hepatology research : the official journal of the Japan Society of Hepatology 2012;42(12):1175-86.
2012: Jisoo A Kwon; Matthew G Law; Lisa Maher; Hla-Hla Thein; Jonathan Anderson; Gregory J Dore; Jenny Iversen; John M Kaldor; Cliff C Kerr; Lei Zhang; David P Wilson
Estimating the cost-effectiveness of needle-syringe programs in Australia.
AIDS (London, England) 2012;26(17):2201-10.
2012: Carla Treloar; Peter Hull; Gregory J Dore; Jason Grebely
Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs.
Drug and alcohol review 2012;31(7):918-24.
2012: Jason Grebely; Margaret Hellard; John M Kaldor; Andrew R Lloyd; Gail V Matthews; Kathy Petoumenos; William Rawlinson; Barbara Yeung; Tanya Applegate; Gregory J Dore; Jordan J Feld; Jacob George
Virological responses during treatment for recent hepatitis C virus: potential benefit for ribavirin use in HCV/HIV co-infection.
AIDS (London, England) 2012;26(13):1653-61.
2012: Heather F Gidding; Paul A W Haber; Matthew G Law; Graeme A Macdonald; George Ostapowicz; Joe J Sasadeusz; Martin Weltman; Janaki Amin; Jacob George; Gregory J Dore
Hepatitis C treatment outcomes in Australian clinics.
The Medical journal of Australia 2012;196(10):633-7.
2012: Gregory J Dore
The changing therapeutic landscape for hepatitis C.
The Medical journal of Australia 2012;196(10):629-32.
2012: Jason Grebely; Margaret Hellard; Georg Lauer; Andrew R Lloyd; William O Osburn; Kimberly Page; Maria Prins; Andrea L Cox; Gregory J Dore
Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccine.
The Lancet infectious diseases 2012;12(5):408-14.
2012: Maryam Alavi; Carolyn Day; Gregory J Dore; Jason Grebely; Paul S Haber; Margaret Hellard; John M Kaldor; Andrew R Lloyd; Gail V Matthews; Kathy Petoumenos; Ingrid van Beek; Barbara Yeung
Effect of pegylated interferon-α-2a treatment on mental health during recent hepatitis C virus infection.
Journal of gastroenterology and hepatology 2012;27(5):957-65.
2012: Jason Grebely; Margaret Hellard; John Kaldor; Andrew Lloyd; Gail V Matthews; Kathy Petoumenos; Son Truong Pham; William Rawlinson; Peter A White; Barbara Yeung; Rowena A Bull; Gregory J Dore
Hepatitis C virus reinfection and superinfection among treated and untreated participants with recent infection.
Hepatology (Baltimore, Md.) 2012;55(4):1058-69.
2011: Jason Grebely; Gregory J Dore
An expanding role for primary care providers in the treatment of hepatitis C virus infection in the community.
Hepatology (Baltimore, Md.) 2011;54(6):2258-60.
2011: Vijayaprakash Suppiah; Martin Weltman; Maria Lorena Abate; Golo Ahlenstiel; Nicola J Armstrong; Margaret Bassendine; Thomas Berg; Pierre-Yves Bochud; David R Booth; Gregory J Dore; David Dunn; Silvana Gaudieri; Jacob George; Emma Hammond; Margaret Hellard; William L Irving; Simon Mallal; Gail Matthews; Tobias Müller; Jacob Nattermann; Francesco Negro; Kate S O'Connor; Elizabeth Powell; Stephen Riordan; David Anthony Sheridan; Antonina Smedile; Ulrich Spengler; Graeme J Stewart
IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional study.
PLoS medicine 2011;8(9):e1001092.
2011: Rowena A Bull; Barbara Cameron; Abha Chopra; Gregory J Dore; Silvana Gaudieri; Fabio Luciani; Lisa Maher; Kerensa McElroy; Son T Pham; Peter White; Andrew R Lloyd
Sequential bottlenecks drive viral evolution in early acute hepatitis C virus infection.
PLoS pathogens 2011;7(9):e1002243.
2011: Heather F Gidding; Janaki Amin; Gregory J Dore; Matthew G Law
Hospitalization rates associated with hepatitis B and HIV co-infection, age and sex in a population-based cohort of people diagnosed with hepatitis C.
Epidemiology and infection 2011;139(8):1151-8.
2011: Hla-Hla Thein; S R Walter; Janaki Amin; J George; Heather F Gidding; Matthew G Law; Gregory J Dore
Trends in incidence of hepatocellular carcinoma after diagnosis of hepatitis B or C infection: a population-based cohort study, 1992-2007.
Journal of viral hepatitis 2011;18(7):e232-41.
2011: Jason Grebely; Paul S Haber; Margaret E Hellard; John M Kaldor; Andrew R Lloyd; Gail V Matthews; Kathy Petoumenos; David Shaw; Ingrid van Beek; Barbara Yeung; Maryam Alavi; Gregory J Dore
Adherence to treatment for recently acquired hepatitis C virus (HCV) infection among injecting drug users.
Journal of hepatology 2011;55(1):76-85.
2011: Jason Grebely; Gail V Matthews; Gregory J Dore
Treatment of acute HCV infection.
Nature reviews. Gastroenterology & hepatology 2011;8(5):265-74.
2011: Scott R Walter; Hla-Hla Thein; Janaki Amin; Heather F Gidding; Kate Ward; Matthew G Law; Jacob George; Gregory J Dore
Trends in mortality after diagnosis of hepatitis B or C infection: 1992-2006.
Journal of hepatology 2011;54(5):879-86.
2011: Jason Grebely; J Bryant; P Hull; M Hopwood; Yvonna Lavis; Gregory J Dore; Carla Treloar
Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, Australia.
Journal of viral hepatitis 2011;18(4):e104-16.
2011: Gail V Matthews; S T Pham; Margaret E Hellard; Jason Grebely; Lei Zhang; A Oon; P Marks; Ingrid van Beek; William D Rawlinson; John M Kaldor; Andrew Lloyd; Gregory J Dore; Peter White
Patterns and characteristics of hepatitis C transmission clusters among HIV-positive and HIV-negative individuals in the Australian trial in acute hepatitis C.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2011;52(6):803-11.
2011: Gail V Matthews; Gregory J Dore
Optimal duration of treatment for acute hepatitis C in human immunodeficiency virus-positive individuals?
Hepatology (Baltimore, Md.) 2011;53(3):1055-6; author reply 1056-7.
2011: Jason Grebely; Gregory J Dore
Prevention of hepatitis C virus in injecting drug users: a narrow window of opportunity.
The Journal of infectious diseases 2011;203(5):571-4.
2011: Jennifer Audsley; Anchalee Avihingsanon; Gregory J Dore; Kit Fairley; Robert Finlayson; Hyon S Hwang; Margaret Littlejohn; Stephen Locarnini; Gail V Matthews; Kiat Ruxrungtham; Joseph Sasadeusz; Eric C Seaberg; Chloe L Thio; Sharon R Lewin
Factors associated with elevated ALT in an international HIV/HBV co-infected cohort on long-term HAART.
PloS one 2011;6(11):e26482.
2011: Heather F Gidding; Gregory J Dore; Janaki Amin; Matthew G Law
Trends in all cause and viral liver disease-related hospitalizations in people with hepatitis B or C: a population-based linkage study.
BMC public health 2011;11():52.
2011: Jason Grebely; Gregory J Dore
Hepatitis C: Enhancing treatment for hepatitis C among drug users.
Nature reviews. Gastroenterology & hepatology 2011;8(1):11-3.
2011: Jason Grebely; J D Raffa; C Lai; T Kerr; B Fischer; Mel Krajden; Gregory J Dore; Mark W Tyndall
Impact of hepatitis C virus infection on all-cause and liver-related mortality in a large community-based cohort of inner city residents.
Journal of viral hepatitis 2011;18(1):32-41.
2010: Jason Grebely; Gail V Matthews; Kathy Petoumenos; Gregory J Dore
Spontaneous clearance and the beneficial impact of treatment on clearance during recent hepatitis C virus infection.
Journal of viral hepatitis 2010;17(12):896.
2010: Jason Grebely; Kathy Petoumenos; Margaret E Hellard; Gail V Matthews; Vijayaprakash Suppiah; Tanya Applegate; Barbara Yeung; Phillipa Marks; William D Rawlinson; Andrew R Lloyd; David Booth; John M Kaldor; Jacob George; Gregory J Dore
Potential role for interleukin-28B genotype in treatment decision-making in recent hepatitis C virus infection.
Hepatology (Baltimore, Md.) 2010;52(4):1216-24.
2010: Jennifer Audsley; Margaret Littlejohn; Lilly Yuen; Joe Sasadeusz; Anna Ayres; Christopher Desmond; Tim Spelman; George Lau; Gail V Matthews; Anchalee Avihingsanon; Eric C Seaberg; FRANCES PHILP; Melissa Saulynas; Kiat Ruxrungtham; Gregory J Dore; Stephen A Locarnini; Chloe L Thio; Sharon R Lewin; Peter Andrew Revill
HBV mutations in untreated HIV-HBV co-infection using genomic length sequencing.
Virology 2010;405(2):539-47.
2010: Jason Grebely; Elizabeth Knight; Tyler Ngai; Krista A Genoway; Jesse D Raffa; Michelle Storms; Lesley Gallagher; Mel Krajden; Gregory J Dore; Fiona Duncan; Brian Conway
Reinfection with hepatitis C virus following sustained virological response in injection drug users.
Journal of gastroenterology and hepatology 2010;25(7):1281-4.
2010: Heather F Gidding; Janaki Amin; Gregory J Dore; Kate Ward; Matthew G Law
Hospital-related morbidity in people notified with hepatitis C: a population-based record linkage study in New South Wales, Australia.
Journal of hepatology 2010;53(1):43-9.
2010: Carolyn A Day; Bethany White; Gregory J Dore; Ingrid van Beek; Craig Rodgers; Philip Cunningham; Alex Wodak; Lisa Maher
Hepatitis B virus among injecting drug users in Sydney, Australia: prevalence, vaccination and knowledge of status.
Drug and alcohol dependence 2010;108(1-2):134-7.
2010: Gregory J Dore; Vicente Soriano; Jürgen Rockstroh; Bernd Kupfer; Ellen Tedaldi; Lars Peters; Jacqueline Neuhaus; Massimo Puoti; Marina B Klein; Amanda Mocroft; Bonaventura Clotet; Jens D Lundgren
Frequent hepatitis B virus rebound among HIV-hepatitis B virus-coinfected patients following antiretroviral therapy interruption.
AIDS (London, England) 2010;24(6):857-65.
2010: Kerry-Lee Milner; David van der Poorten; Michael Trenell; Arthur B Jenkins; Aimin Xu; George Smythe; Gregory J Dore; Amany Zekry; Martin Weltman; Vincent Fragomeli; Jacob George; Donald J Chisholm
Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance.
Gastroenterology 2010;138(3):932-41.e1-3.
2010: Jason Grebely; Kathy Petoumenos; Gail V Matthews; Paul S Haber; P Marks; Andrew R Lloyd; John M Kaldor; Gregory J Dore; Margaret E Hellard
Factors associated with uptake of treatment for recent hepatitis C virus infection in a predominantly injecting drug user cohort: The ATAHC Study.
Drug and alcohol dependence 2010;107(2-3):244-9.
2010: Suzy Teutsch; Fabio Luciani; Nicolas Scheuer; Luke McCredie; Parastu Hosseiny; William D Rawlinson; John Kaldor; Gregory J Dore; Kate Dolan; Rosemary A Ffrench; Andrew Lloyd; Paul Haber; Michael Levy
Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort.
BMC public health 2010;10():633.
2010: Anchalee Avihingsanon; Sharon R Lewin; Stephen Kerr; Judy J Chang; Komolmit Piyawat; Nounpen Napissanant; Gail V Matthews; Gregory J Dore; Scott Bowden; Joep Lange; Kiat Ruxrungtham
Efficacy of tenofovir disoproxil fumarate/emtricitabine compared with emtricitabine alone in antiretroviral-naive HIV-HBV coinfection in Thailand.
Antiviral therapy 2010;15(6):917-22.
2010: Gregory J Dore; Margaret E Hellard; Gail V Matthews; Jason Grebely; Paul S Haber; Kathy Petoumenos; Barbara Yeung; Philippa Marks; Ingrid van Beek; Geoffrey McCaughan; Peter White; Rosemary French; William D Rawlinson; Andrew R Lloyd; John M Kaldor
Effective treatment of injecting drug users with recently acquired hepatitis C virus infection.
Gastroenterology 2010;138(1):123-35.e1-2.
2009: Heather F Gidding; Libby Topp; Melanie Middleton; Kate Robinson; Margaret E Hellard; Geoffrey McCaughan; Lisa Maher; John M Kaldor; Gregory J Dore; Matthew G Law
The epidemiology of hepatitis C in Australia: notifications, treatment uptake and liver transplantations, 1997-2006.
Journal of gastroenterology and hepatology 2009;24(10):1648-54.
2009: Vijayaprakash Suppiah; Max Moldovan; Golo Ahlenstiel; Thomas Berg; Martin Weltman; Maria Lorena Abate; Margaret Bassendine; Ulrich Spengler; Gregory J Dore; Elizabeth Powell; Stephen Riordan; David Anthony Sheridan; Antonina Smedile; Vincenzo Fragomeli; Tobias Müller; Melanie Bahlo; Graeme J Stewart; David R Booth; Jacob George
IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy.
Nature genetics 2009;41(10):1100-4.
2009: Jason Grebely; David L Thomas; Gregory J Dore
HCV reinfection studies and the door to vaccine development.
Journal of hepatology 2009;51(4):628-31.
2009: Anna Doab; Libby Topp; Carolyn A Day; Gregory J Dore; Lisa Maher
Clinical trial literacy among injecting drug users in Sydney, Australia: A pilot study.
Contemporary clinical trials 2009;30(5):431-5.
2009: Gail V Matthews; Eric C Seaberg; Gregory J Dore; Scott Bowden; Sharon R Lewin; Joe Sasadeusz; Pip Marks; Zachary Goodman; FRANCES PHILP; Yiwei Tang; Stephen Locarnini; Chloe L Thio
Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individuals.
AIDS (London, England) 2009;23(13):1707-15.
2009: V T T Nguyen; Matthew G Law; Gregory J Dore
Hepatitis B-related hepatocellular carcinoma: epidemiological characteristics and disease burden.
Journal of viral hepatitis 2009;16(7):453-63.
2009: Gail V Matthews; Margaret E Hellard; P Haber; B Yeung; P Marks; D Baker; G McCaughan; J Sasadeusz; P White; William D Rawlinson; A Lloyd; John Kaldor; Gregory J Dore
Characteristics and treatment outcomes among HIV-infected individuals in the Australian Trial in Acute Hepatitis C.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(5):650-8.
2009: Van T T Nguyen; Janaki Amin; Matthew G Law; Gregory J Dore
Predictors and survival in hepatitis B-related hepatocellular carcinoma in New South Wales, Australia.
Journal of gastroenterology and hepatology 2009;24(3):436-42.
2008: Gregory J Dore; Paul S Haber
Tell me it ain't so: patient-to-patient transmission of hepatitis C in an endoscopy clinic.
Hepatology (Baltimore, Md.) 2008;48(4):1333-5.
2008: Hla-Hla Thein; Qilong Yi; Gregory J Dore; Murray D Krahn
Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis.
AIDS (London, England) 2008;22(15):1979-91.
2008: Gail V Matthews; Anchalee Avihingsanon; Sharon R Lewin; Janaki Amin; Rungsun Rerknimitr; Panusit Petcharapirat; Pip Marks; Joe Sasadeusz; David A Cooper; Scott Bowden; Stephen Locarnini; Kiat Ruxrungtham; Gregory J Dore
A randomized trial of combination hepatitis B therapy in HIV/HBV coinfected antiretroviral naïve individuals in Thailand.
Hepatology (Baltimore, Md.) 2008;48(4):1062-9.
2008: Gail V Matthews; Jason Grebely; Gregory J Dore
The role of re-infection in determining rates of spontaneous clearance after hepatitis C exposure.
Journal of hepatology 2008;49(3):305-7.
2008: Scott Preiss; Margaret Littlejohn; Peter W Angus; Alex Thompson; Paul Desmond; Sharon R Lewin; Joseph Sasadeusz; Gail Matthews; Gregory J Dore; Tim Shaw; Vitini Sozzi; Lilly Yuen; George Lau; Anna Ayres; Chloe L Thio; Anchalee Avihingsanon; Kiat Ruxrungtham; Stephen Locarnini; Peter Andrew Revill
Defective hepatitis B virus DNA is not associated with disease status but is reduced by polymerase mutations associated with drug resistance.
Hepatology (Baltimore, Md.) 2008;48(3):741-9.
2008: Hla-Hla Thein; Qilong Yi; Gregory J Dore; Murray D Krahn
Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regression.
Hepatology (Baltimore, Md.) 2008;48(2):418-31.
2008: Gail V Matthews; Gregory J Dore
HIV and hepatitis C coinfection.
Journal of gastroenterology and hepatology 2008;23(7 Pt 1):1000-8.
2008: Van Thi Thuy Nguyen; Karina Razali; Janaki Amin; Matthew G Law; Gregory J Dore
Estimates and projections of hepatitis B-related hepatocellular carcinoma in Australia among people born in Asia-Pacific countries.
Journal of gastroenterology and hepatology 2008;23(6):922-9.
2008: Van Thi Thuy Nguyen; Matthew G Law; Gregory J Dore
An enormous hepatitis B virus-related liver disease burden projected in Vietnam by 2025.
Liver international : official journal of the International Association for the Study of the Liver 2008;28(4):525-31.
2008: C A Day; Bethany White; Hla-Hla Thein; A Doab; Gregory J Dore; A Bates; J Holden; Lisa Maher
Experience of hepatitis C testing among injecting drug users in Sydney, Australia.
AIDS care 2008;20(1):116-23.
2007: Karina Razali; Hla-Hla Thein; Jane Bell; Mark Cooper-Stanbury; Kate Dolan; Gregory J Dore; Jacob George; John Kaldor; Maria Karvelas; Jiong Li; Lisa Maher; Sharyn McGregor; Margaret E Hellard; Fiona Poeder; Julianne Quaine; Kim Stewart; Helen Tyrrell; Martin Weltman; Owen Westcott; Alex Wodak; Matthew Law
Modelling the hepatitis C virus epidemic in Australia.
Drug and alcohol dependence 2007;91(2-3):228-35.
2007: Van Thi-Thuy Nguyen; Mary-Louise Mclaws; Gregory J Dore
Highly endemic hepatitis B infection in rural Vietnam.
Journal of gastroenterology and hepatology 2007;22(12):2093-100.
2007: Hla-Hla Thein; P Maruff; M D Krahn; John M Kaldor; D J Koorey; B J Brew; Gregory J Dore
Improved cognitive function as a consequence of hepatitis C virus treatment.
HIV medicine 2007;8(8):520-8.
2007: Janaki Amin; Dianne O'Connell; Mark Bartlett; Elizabeth Tracey; John Kaldor; Matthew Law; Gregory J Dore
Liver cancer and hepatitis B and C in New South Wales, 1990-2002: a linkage study.
Australian and New Zealand journal of public health 2007;31(5):475-82.
2007: Gail V Matthews; Margaret E Hellard; John Kaldor; Andrew Lloyd; Gregory J Dore
Further evidence of HCV sexual transmission among HIV-positive men who have sex with men: response to Danta et al.
AIDS (London, England) 2007;21(15):2112-3.
2007: Van Thi Thuy Nguyen; Mary-Louise Mclaws; Gregory J Dore
Prevalence and risk factors for hepatitis C infection in rural north Vietnam.
Hepatology international 2007;1(3):387-93.
2007: Jialun Zhou; Gregory J Dore; Fujie Zhang; Poh Lian Lim; Yi-Ming A Chen
Hepatitis B and C virus coinfection in The TREAT Asia HIV Observational Database.
Journal of gastroenterology and hepatology 2007;22(9):1510-8.
2007: Peter Andrew Revill; Margaret Littlejohn; Anna Ayres; Lilly Yuen; Danni Colledge; Angeline Bartholomeusz; Joe Sasaduesz; Sharon R Lewin; Gregory J Dore; Gail V Matthews; Chloe L Thio; Stephen A Locarnini
Identification of a novel hepatitis B virus precore/core deletion mutant in HIV/hepatitis B virus co-infected individuals.
AIDS (London, England) 2007;21(13):1701-10.
2007: Gregory J Dore; Francesca J Torriani; Maribel Rodriguez-Torres; Norbert Bräu; Mark S Sulkowski; Ricard Sola Lamoglia; Cristina Tural; Nathan Clumeck; Mark R Nelson; Maria C Mendes-Correa; Eliot W Godofsky; Douglas T Dieterich; Ellen Yetzer; Eduardo Lissen; David A Cooper
Baseline factors prognostic of sustained virological response in patients with HIV-hepatitis C virus co-infection.
AIDS (London, England) 2007;21(12):1555-9.
2007: Joanne M Micallef; Virginia Macdonald; Marianne Jauncey; Janaki Amin; William D Rawlinson; Ingrid van Beek; John M Kaldor; Peter White; Gregory J Dore
High incidence of hepatitis C virus reinfection within a cohort of injecting drug users.
Journal of viral hepatitis 2007;14(6):413-8.
2007: Hla-Hla Thein; P Maruff; M Krahn; John Kaldor; Dj Koorey; Bj Brew; Gregory J Dore
Cognitive function, mood and health-related quality of life in hepatitis C virus (HCV)-monoinfected and HIV/HCV-coinfected individuals commencing HCV treatment.
HIV medicine 2007;8(3):192-202.
2007: Gail V Matthews; Gregory J Dore
Response to Schmutz et al., 'Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection'.
AIDS (London, England) 2007;21(6):777-8.
2007: Virginia Macdonald; Gregory J Dore; Janaki Amin; Ingrid van Beek
Predictors of completion of a hepatitis B vaccination schedule in attendees at a primary health care centre.
Sexual health 2007;4(1):27-30.
2007: Gail V Matthews; David A Cooper; Gregory J Dore
Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovir.
Antiviral therapy 2007;12(1):119-22.
2007: Janaki Amin; M G Law; J Micallef; Marianne Jauncey; Ingrid van Beek; John M Kaldor; Gregory J Dore
Potential biases in estimates of hepatitis C RNA clearance in newly acquired hepatitis C infection among a cohort of injecting drug users.
Epidemiology and infection 2007;135(1):144-50.
2006: Ben J Smith; Adrian E Bauman; Jack Chen; Stuart Loveday; Melanie Costello; Brent Mackie; Gregory J Dore
Hepatitis C in Australia: impact of a mass media campaign.
American journal of preventive medicine 2006;31(6):492-8.
2006: Janaki Amin; Matthew G Law; Mark Bartlett; John M Kaldor; Gregory J Dore
Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study.
Lancet 2006;368(9539):938-45.
2006: Gregory J Dore; David A Cooper
HAART's first decade: success brings further challenges.
Lancet 2006;368(9534):427-8.
2006: Janaki Amin; Gregory J Dore; Dianne L O'Connell; Mark Bartlett; Elizabeth Tracey; John M Kaldor; Matthew G Law
Cancer incidence in people with hepatitis B or C infection: a large community-based linkage study.
Journal of hepatology 2006;45(2):197-203.
2006: Gail V Matthews; Angeline Bartholomeusz; Stephen Locarnini; Anna Ayres; Joe Sasaduesz; Eric C Seaberg; David A Cooper; Sharon Lewin; Gregory J Dore; Chloe L Thio
Characteristics of drug resistant HBV in an international collaborative study of HIV-HBV-infected individuals on extended lamivudine therapy.
AIDS (London, England) 2006;20(6):863-70.
2006: Hla-Hla Thein; Tony Butler; Murray Krahn; William D Rawlinson; Michael H Levy; John M Kaldor; Gregory J Dore
The effect of hepatitis C virus infection on health-related quality of life in prisoners.
Journal of urban health : bulletin of the New York Academy of Medicine 2006;83(2):275-88.
2006: Joanne M Micallef; John M Kaldor; Gregory J Dore
Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies.
Journal of viral hepatitis 2006;13(1):34-41.
2005: Gail Matthews; Ian J Kronborg; Gregory J Dore
Treatment for hepatitis C virus infection among current injection drug users in Australia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40 Suppl 5():S325-9.
2005: Anna Doab; Carla Treloar; Gregory J Dore
Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40 Suppl 5():S313-20.
2005: Hla-Hla Thein; Murray Krahn; John M Kaldor; Gregory J Dore
Estimation of utilities for chronic hepatitis C from SF-36 scores.
The American journal of gastroenterology 2005;100(3):643-51.
2005: Gregory J Dore; David L Thomas
Management and treatment of injection drug users with hepatitis C virus (HCV) infection and HCV/human immunodeficiency virus coinfection.
Seminars in liver disease 2005;25(1):18-32.
2005: Chris Duncombe; Stephen J Kerr; Kiat Ruxrungtham; Gregory J Dore; Matthew G Law; Sean Emery; Joep M A Lange; Praphan Phanuphak; David A Cooper
HIV disease progression in a patient cohort treated via a clinical research network in a resource limited setting.
AIDS (London, England) 2005;19(2):169-78.
2004: Marianne Jauncey; Joanne M Micallef; Stuart Gilmour; Janaki Amin; Peter White; William D Rawlinson; John M Kaldor; Ingrid van Beek; Gregory J Dore
Clearance of hepatitis C virus after newly acquired infection in injection drug users.
The Journal of infectious diseases 2004;190(7):1270-4.
2004: Belinda G O'Sullivan; Heather F Gidding; Matthew Law; John M Kaldor; Gwendolyn L Gilbert; Gregory J Dore
Estimates of chronic hepatitis B virus infection in Australia, 2000.
Australian and New Zealand journal of public health 2004;28(3):212-6.
2004: W. Phillip Law; Chris Duncombe; Apicha Mahanontharit; Mark A Boyd; Kiat Ruxrungtham; Joep M A Lange; Praphan Phanuphak; David A Cooper; Gregory J Dore
Impact of viral hepatitis co-infection on response to antiretroviral therapy and HIV disease progression in the HIV-NAT cohort.
AIDS (London, England) 2004;18(8):1169-77.
2004: Janaki Amin; M Kaye; S Skidmore; D Pillay; David A Cooper; Gregory J Dore
HIV and hepatitis C coinfection within the CAESAR study.
HIV medicine 2004;5(3):174-9.
2004: Gregory J Dore; David A Cooper; Anton L Pozniak; Edwin DeJesus; Lijie Zhong; Michael D Miller; Biao Lu; Andrew K Cheng
Efficacy of tenofovir disoproxil fumarate in antiretroviral therapy-naive and -experienced patients coinfected with HIV-1 and hepatitis B virus.
The Journal of infectious diseases 2004;189(7):1185-92.
2004: Monica C Robotin; Joy Copland; Graham Tallis; David Coleman; Carolien Giele; Louise Carter; Jenean Spencer; John M Kaldor; Gregory J Dore
Surveillance for newly acquired hepatitis C in Australia.
Journal of gastroenterology and hepatology 2004;19(3):283-8.
2004: Janaki Amin; Heather F Gidding; Gwendolyn Gilbert; Josephine Backhouse; John Kaldor; Gregory J Dore; Margaret Burgess
Hepatitis C prevalence--a nationwide serosurvey.
Communicable diseases intelligence quarterly report 2004;28(4):517-21.
2003: Narin Hiransuthikul; Mattana Hanvanich; Gregory J Dore; Thawatchai Mokkhawes; Yueming Li; Jos Perriens; John M Kaldor
Factors associated with tuberculin skin test reactivity among HIV-infected people in Bangkok.
The Southeast Asian journal of tropical medicine and public health 2003;34(4):804-9.
2003: Ann M McDonald; Yueming Li; Gregory J Dore; Hugo Ree; John M Kaldor
Late HIV presentation among AIDS cases in Australia, 1992-2001.
Australian and New Zealand journal of public health 2003;27(6):608-13.
2003: Hla-Hla Thein; Paul S Haber; Gregory J Dore
Quality of life of women living with hepatitis C.
Journal of gastroenterology and hepatology 2003;18(12):1329-31.
2003: Gregory J Dore
Antiretroviral therapy-related hepatotoxicity: predictors and clinical management.
Journal of HIV therapy 2003;8(4):96-100.
2003: W. Phillip Law; Gregory J Dore; Chris Duncombe; Apicha Mahanontharit; Mark A Boyd; Kiat Ruxrungtham; Joep M A Lange; Praphan Phanuphak; David A Cooper
Risk of severe hepatotoxicity associated with antiretroviral therapy in the HIV-NAT Cohort, Thailand, 1996-2001.
AIDS (London, England) 2003;17(15):2191-9.
2003: Gregory J Dore; Hla-Hla Thein
Cost-effectiveness of treatment for chronic hepatitis C infection.
JAMA : the journal of the American Medical Association 2003;290(15):1993; author reply 1994.
2003: Gregory J Dore; Anthony J Freeman; Matthew Law; John M Kaldor
Natural history models for hepatitis C-related liver disease: different disease progression parameters for different settings.
Antiviral therapy 2003;8(5):365-72.
2003: Gregory J Dore; Margaret MacDonald; Matthew G Law; John M Kaldor
Epidemiology of hepatitis C virus infection in Australia.
Australian family physician 2003;32(10):796-8.
2003: Matthew G Law; Gregory J Dore; Nicky Bath; Sandra Thompson; Nick Crofts; Kate Dolan; Wendy Giles; Paul Gow; John Kaldor; Stuart Loveday; Elizabeth Powell; Jenean Spencer; Alex Wodak
Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001.
International journal of epidemiology 2003;32(5):717-24.
2003: Gregory J Dore; Ann McDonald; Yueming Li; John M Kaldor; Bruce J Brew
Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy.
AIDS (London, England) 2003;17(10):1539-45.
2003: D Lincoln; Kathy Petoumenos; Gregory J Dore
HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy.
HIV medicine 2003;4(3):241-9.
2003: Anthony J Freeman; Matthew G Law; John M Kaldor; Gregory J Dore
Predicting progression to cirrhosis in chronic hepatitis C virus infection.
Journal of viral hepatitis 2003;10(4):285-93.
2003: Gregory J Dore; Matthew Law; Margaret MacDonald; John M Kaldor
Epidemiology of hepatitis C virus infection in Australia.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2003;26(2):171-84.
2002: Mark Danta; Gregory J Dore; Lisa Hennessy; Yueming Li; Chris R Vickers; Hugh Harley; Meng Ngu; William Reed; Paul V Desmond; William Sievert; Geoff C Farrell; John M Kaldor; Robert G Batey
Factors associated with severity of hepatic fibrosis in people with chronic hepatitis C infection.
The Medical journal of Australia 2002;177(5):240-5.
2002: Gregory J Dore; Anthony J Freeman; Matthew Law; John M Kaldor
Is severe liver disease a common outcome for people with chronic hepatitis C?
Journal of gastroenterology and hepatology 2002;17(4):423-30.
2002: Gregory J Dore; Yueming Li; Ann McDonald; Hugo Ree; John M Kaldor; John M Kaldo
Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia.
Journal of acquired immune deficiency syndromes (1999) 2002;29(4):388-95.
2001: Gregory J Dore; David A Cooper
The impact of HIV therapy on co-infection with hepatitis B and hepatitis C viruses.
Current opinion in infectious diseases 2001;14(6):749-55.
2001: Anthony J Freeman; Gregory J Dore; Matthew G Law; M Thorpe; J Von Overbeck; Andrew R Lloyd; George Marinos; John M Kaldor
Estimating progression to cirrhosis in chronic hepatitis C virus infection.
Hepatology (Baltimore, Md.) 2001;34(4 Pt 1):809-16.
2001: Gregory J Dore; Yueming Li; Ann McDonald; John M Kaldor
Spectrum of AIDS-defining illnesses in Australia, 1992 to 1998: influence of country/region of birth.
Journal of acquired immune deficiency syndromes (1999) 2001;26(3):283-90.
2000: Yueming Li; Ann M McDonald; Gregory J Dore; John M Kaldor
Improving survival following AIDS in Australia, 1991-1996. National HIV Surveillance Committee.
AIDS (London, England) 2000;14(15):2349-54.
2000: Matthew G Law; S K Roberts; Gregory J Dore; John M Kaldor
Primary hepatocellular carcinoma in Australia, 1978-1997: increasing incidence and mortality.
The Medical journal of Australia 2000;173(8):403-5.
2000: Gregory J Dore
Infectious diseases in the 21st century. Are we entering the hot zone?
Australian family physician 2000;29(7):627-30.
2000: John M Kaldor; Gregory J Dore; Patty Correll
Public health challenges in hepatitis C virus infection.
Journal of gastroenterology and hepatology 2000;15 Suppl():E83-90.
2000: J A Guthrie; Gregory J Dore; Ann M McDonald; John M Kaldor
HIV and AIDS in aboriginal and Torres Strait Islander Australians: 1992-1998. The National HIV Surveillance Committee.
The Medical journal of Australia 2000;172(6):266-9.
1999: Gregory J Dore; M G Law; J M Kaldor
Prevalence of hepatitis C virus infection in the United States.
The New England journal of medicine 1999;341(27):2093-4; author reply 2094-5.
1999: Gregory J Dore; David A Cooper; C Barrett; L E Goh; B Thakrar; M Atkins
Dual efficacy of lamivudine treatment in human immunodeficiency virus/hepatitis B virus-coinfected persons in a randomized, controlled study (CAESAR). The CAESAR Coordinating Committee.
The Journal of infectious diseases 1999;180(3):607-13.
1999: Gregory J Dore; Patty Correll; Yueming Li; John M Kaldor; David A Cooper; Bruce J Brew
Changes to AIDS dementia complex in the era of highly active antiretroviral therapy.
AIDS (London, England) 1999;13(10):1249-53.
1998: Ingrid van Beek; R Dwyer; Gregory J Dore; K Luo; John M Kaldor
Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: retrospective cohort study.
BMJ (Clinical research ed.) 1998;317(7156):433-7.
1998: Gregory J Dore; Yueming Li; A J Plant; John M Kaldor
Trends in infectious disease mortality in Australia, 1979-1994.
The Medical journal of Australia 1998;168(12):601-4.
1998: Gregory J Dore; T Brown; Daniel Tarantola; John M Kaldor
HIV and AIDS in the Asia-Pacific region: an epidemiological overview.
AIDS (London, England) 1998;12 Suppl B():S1-10.
1997: Gregory J Dore; M G Law; J M Kaldor
Isoniazid prophylaxis for high-risk patients with anergy and HIV infection.
The New England journal of medicine 1997;337(23):1697.
1997: Gregory J Dore; Jennifer Hoy; Simon Mallal; Yueming Li; Anne Mijch; Martyn A French; David A Cooper; John M Kaldor
Trends in incidence of AIDS illnesses in Australia from 1983 to 1994: the Australian AIDS cohort.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;16(1):39-43.
1997: Gregory J Dore; John M Kaldor; G W McCaughan
Systematic review of role of polymerase chain reaction in defining infectiousness among people infected with hepatitis C virus.
BMJ (Clinical research ed.) 1997;315(7104):333-7.
1997: J A Gray; Gregory J Dore; Yueming Li; S Supawitkul; P Effler; John M Kaldor
HIV-1 infection among female commercial sex workers in rural Thailand.
AIDS (London, England) 1997;11(1):89-94.
1996: Gregory J Dore; John M Kaldor; K Ungchusak; T E Mertens
Epidemiology of HIV and AIDS in the Asia-Pacific region.
The Medical journal of Australia 1996;165(9):494-8.
1996: Matthew G Law; Gregory J Dore; A McDonald; J Kaldor
The use of back projection to estimate HIV prevalence among pregnant women in Australia.
Pediatric AIDS and HIV infection 1996;7(5):331-6.
1996: Gregory J Dore; Yueming Li; Andrew E Grulich; Jennifer Hoy; Simon Mallal; Anne Mijch; Martyn A French; David A Cooper; John M Kaldor
Declining incidence and later occurrence of Kaposi's sarcoma among persons with AIDS in Australia: the Australian AIDS cohort.
AIDS (London, England) 1996;10(12):1401-6.
1996: D L Couldwell; Gregory J Dore; John Harkness; Deborah Marriott; David A Cooper; R Edwards; Yueming Li; John M Kaldor
Nosocomial outbreak of tuberculosis in an outpatient HIV treatment room.
AIDS (London, England) 1996;10(5):521-5.
1996: Gregory J Dore; M G Law; B J Brew
Prospective analysis of seizures occurring in human immunodeficiency virus type-1 infection.
Journal of neuro-AIDS 1996;1(4):59-69.
1995: Gregory J Dore; Deborah Marriott; J A Duflou
Clinico-pathological study of cytomegalovirus (CMV) in AIDS autopsies: under-recognition of CMV pneumonitis and CMV adrenalitis.
Australian and New Zealand journal of medicine 1995;25(5):503-6.
1995: Gregory J Dore; Deborah Marriott; M C Hing; John Harkness; A S Field
Disseminated microsporidiosis due to Septata intestinalis in nine patients infected with the human immunodeficiency virus: response to therapy with albendazole.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;21(1):70-6.